Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -747.29%-72.12M | ---- | 110.16%11.14M | ---- | 57.76%-109.66M | ---- | -145.12%-259.61M | ---- | -790.46%-105.91M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -332.93%-1.78M | ---- | -1,142.42%-410K | ---- | -100.50%-33K | ---- | 1,108.66%6.64M | ---- | 93.22%-658K |
| Attributable subsidiary (profit) loss | ---- | --181K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.17%1.95M |
| Impairment and provisions: | ---- | 112.12%6.54M | ---- | -179.87%-53.96M | ---- | -60.92%67.56M | ---- | 2,075.58%172.89M | ---- | 7,071.05%7.95M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --6M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | -200.00%-1.56M | ---- | -7.52%1.56M | ---- | 1,284.43%1.69M |
| -Impairment of trade receivables (reversal) | ---- | 245.30%625K | ---- | 1,052.63%181K | ---- | -100.02%-19K | ---- | --122.71M | ---- | ---- |
| -Impairment of goodwill | ---- | --8.04M | ---- | ---- | ---- | -93.03%3.39M | ---- | --48.62M | ---- | ---- |
| -Other impairments and provisions | ---- | 96.08%-2.12M | ---- | -190.62%-54.14M | ---- | --59.75M | ---- | ---- | ---- | 2,751.69%6.26M |
| Revaluation surplus: | ---- | 30,444.44%54.98M | ---- | 111.23%180K | ---- | -197.03%-1.6M | ---- | -38.88%1.65M | ---- | 439.52%2.7M |
| -Other fair value changes | ---- | 30,444.44%54.98M | ---- | 111.23%180K | ---- | -197.03%-1.6M | ---- | -38.88%1.65M | ---- | 439.52%2.7M |
| Asset sale loss (gain): | ---- | 645.20%2.73M | ---- | -134.82%-500K | ---- | 103.30%1.44M | ---- | -19,705.91%-43.57M | ---- | -307.55%-220K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 645.20%2.73M | ---- | -65.56%-500K | ---- | 99.27%-302K | ---- | ---41.35M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 178.15%1.74M | ---- | -910.91%-2.22M | ---- | ---220K |
| Depreciation and amortization: | ---- | -11.46%14.07M | ---- | 39.53%15.89M | ---- | 2.86%11.39M | ---- | -13.32%11.07M | ---- | -1.71%12.77M |
| -Amortization of intangible assets | ---- | -0.24%838K | ---- | 504.32%840K | ---- | 23.01%139K | ---- | -89.98%113K | ---- | -9.11%1.13M |
| Financial expense | ---- | -21.62%9.14M | ---- | 34.66%11.67M | ---- | 40.00%8.66M | ---- | -21.80%6.19M | ---- | -16.96%7.91M |
| Exchange Loss (gain) | ---- | 0.75%-531K | ---- | -144.29%-535K | ---- | -147.20%-219K | ---- | -52.80%464K | ---- | 205.36%983K |
| Special items | ---- | ---105K | ---- | ---- | ---- | ---- | ---- | 9.05%115.98M | ---- | 1,975.14%106.35M |
| Operating profit before the change of operating capital | ---- | 179.32%13.11M | ---- | 26.44%-16.53M | ---- | -291.92%-22.47M | ---- | -65.40%11.71M | ---- | -3.04%33.83M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -56.39%8.47M | ---- | 370.69%19.41M | ---- | -174.54%-7.17M | ---- | -105.74%-2.61M | ---- | 174.59%45.51M |
| Accounts receivable (increase)decrease | ---- | 98.43%-953K | ---- | -96.14%-60.69M | ---- | -199.82%-30.94M | ---- | 170.89%31M | ---- | 53.51%-43.73M |
| Accounts payable increase (decrease) | ---- | 32,718.66%199.3M | ---- | -103.10%-611K | ---- | 332.37%19.68M | ---- | 79.08%-8.47M | ---- | -162.02%-40.49M |
| prepayments (increase)decrease | ---- | -109.59%-3.66M | ---- | 1,188.15%38.19M | ---- | 68.36%-3.51M | ---- | 27.18%-11.1M | ---- | -13.30%-15.24M |
| Special items for working capital changes | ---- | -461.11%-215.17M | ---- | 37.95%59.59M | ---- | 744.13%43.19M | ---- | 177.20%5.12M | ---- | 95.87%-6.63M |
| Cash from business operations | ---- | -97.23%1.09M | ---- | 3,337.01%39.36M | ---- | -104.74%-1.22M | ---- | 195.88%25.65M | ---- | 88.30%-26.75M |
| Other taxs | ---- | 244.85%478K | ---- | -176.57%-330K | ---- | 118.24%431K | ---- | -6.54%-2.36M | ---- | -2,192.45%-2.22M |
| Special items of business | 616.46%85.6M | ---- | 1,274.73%11.95M | ---- | -110.12%-1.02M | ---- | -47.46%10.05M | ---- | 175.53%19.14M | ---- |
| Net cash from operations | 616.46%85.6M | -95.99%1.57M | 1,274.73%11.95M | 5,072.23%39.03M | -110.12%-1.02M | -103.37%-785K | -47.46%10.05M | 180.38%23.28M | 175.53%19.14M | 87.33%-28.97M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 1,626.92%898K | 294.88%1.62M | --52K | 1,142.42%410K | ---- | -75.91%33K | ---- | -79.18%137K | ---- | -93.22%658K |
| Dividend received - investment | --1.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | 200.00%14.98M | --14.98M | ---14.98M | ---- | ---- | ---- | 8,191.21%41.43M | ---- | 98.75%-512K |
| Sale of fixed assets | ---- | -99.60%2K | ---- | -24.81%500K | ---- | -99.15%665K | ---- | --77.82M | ---- | ---- |
| Purchase of fixed assets | -95.43%-4.11M | -148.50%-2.15M | ---2.1M | 77.20%-864K | ---- | -745.76%-3.79M | ---- | 59.31%-448K | ---- | -137.28%-1.1M |
| Sale of subsidiaries | ---60K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---4.65M | ---6.66M | ---- | ---- | ---- | ---7.69M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | --48.09M | --15M | ---- | ---- | -89.13%340K | ---- | 752.59%3.13M | ---- | --367K |
| Cash on investment | 99.54%-126K | -1,076.99%-50.85M | ---27.32M | ---4.32M | ---- | ---- | ---- | 90.06%-1.47M | ---- | -6,632.16%-14.83M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | -57.89%638K | ---- | 513.36%1.52M | ---- |
| Net cash from investment operations | -1,156.91%-6.5M | 126.19%5.04M | --615K | -84.39%-19.26M | ---- | -108.66%-10.44M | -57.89%638K | 882.21%120.59M | 513.36%1.52M | -35.73%-15.42M |
| Net cash before financing | 529.64%79.1M | -66.58%6.61M | 1,335.20%12.56M | 276.13%19.78M | -109.51%-1.02M | -107.80%-11.23M | -48.22%10.69M | 424.17%143.87M | 182.31%20.65M | 81.50%-44.38M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --4.68M | -30.89%87M | ---- | -23.59%125.89M | ---- | -83.24%164.74M | ---- | -39.80%983.11M | ---- | 152.43%1.63B |
| Refund | 99.46%-111K | 29.94%-122.94M | ---20.45M | 3.34%-175.48M | ---- | 84.10%-181.55M | ---- | 29.92%-1.14B | ---- | -253.10%-1.63B |
| Issuing shares | ---- | ---- | ---- | 269.56%81.01M | ---- | --21.92M | ---- | ---- | ---- | ---- |
| Interest paid - financing | -4.48%-4.62M | 24.96%-9.14M | ---4.42M | -35.45%-12.19M | ---- | -35.09%-9M | ---- | 15.33%-6.66M | ---- | 11.21%-7.87M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---500K |
| Absorb investment income | --2M | ---- | ---- | --598K | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---4.01M | ---4.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | -273.04%-661K | ---- | --382K | 61.35%6.08M | ---- | 484.18%3.77M | ---- | 95.06%-980K | ---- |
| Net cash from financing operations | 102.28%705K | -419.18%-52.81M | -610.11%-30.99M | 477.98%16.54M | 61.35%6.08M | 97.35%-4.38M | 484.18%3.77M | -3,648.66%-165.24M | 95.06%-980K | -102.83%-4.41M |
| Effect of rate | 481.98%646K | -19.51%363K | 206.73%111K | 569.79%451K | -112.24%-104K | 62.06%-96K | 41.67%-49K | 58.32%-253K | -110.00%-84K | -316.79%-607K |
| Net Cash | 533.07%79.8M | -227.19%-46.2M | -464.31%-18.43M | 332.75%36.32M | -65.01%5.06M | 26.99%-15.61M | -26.50%14.46M | 56.19%-21.37M | 143.79%19.67M | 42.13%-48.79M |
| Begining period cash | -67.67%21.9M | 118.77%67.73M | 118.77%67.73M | -33.65%30.96M | -33.65%30.96M | -31.67%46.66M | -31.67%46.66M | -41.97%68.29M | -41.97%68.29M | -41.66%117.68M |
| Cash at the end | 107.12%102.35M | -67.67%21.9M | 37.59%49.41M | 118.77%67.73M | -41.19%35.91M | -33.65%30.96M | -30.50%61.07M | -31.67%46.66M | 20.83%87.87M | -41.97%68.29M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianzhi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.